novel miR-56对罗氏沼虾免疫相关基因表达的调节作用

Regulatory role of novel miR-56 on the expression of immunerelated genes in Macrobrachium rosenbergii

  • 摘要: 【目的】 揭示novel miR-56对罗氏沼虾免疫相关基因的调节机制,为进一步探究miRNA参与罗氏沼虾先天免疫调节提供理论依据。【方法】 以实时荧光定量PCR检测副溶血弧菌感染后罗氏沼虾鳃组织中的novel miR-56表达变化,采用RNAhybrid预测筛选出novel miR-56的潜在靶基因TLR1,通过双荧光素酶报告基因检测验证novel miR-56与靶基因TLR1的靶向关系;体外注射不同剂量(0.6、1.0和1.5μg/g)的agomiR-56和antagomiR-56干扰novel miR-56表达,筛选出agomiR-56和antagomiR-56的最佳注射剂量,并以实时荧光定量PCR检测罗氏沼虾免疫相关基因的表达变化。【结果】 感染副溶血弧菌后,罗氏沼虾鳃组织中的novel miR-56相对表达量随感染时间的推移呈逐渐上升趋势,至感染后72 h,novel miR-56相对表达量约是感染前(0 h)的6.18倍。TLR1是novel miR-56的靶基因,二者的结合位点位于TLR1基因3'非编码区(3'-UTR),且novel miR-56过表达会抑制TLR1基因的表达。于罗氏沼虾围心腔注射0.6、1.0和1.5μg/g的agomiR-56均能显著抑制TLR1基因表达(P<0.05,下同),且以1.5μg/g agomiR-56的抑制效果最优;罗氏沼虾其他免疫相关基因(SpzTLR2TLR3MyD88IMDCrustin1WntlessALF1proPO)在注射agomiR-56后的相对表达量也显著降低。antagomiR-56注射试验结果则恰好相反,注射不同剂量的antagomiR-56对罗氏沼虾TLR1基因有显著促进效果,且随着注射剂量的升高,对罗氏沼虾TLR1基因表达的促进效果呈先上升后下降的变化趋势,以1.0μg/g为antgomiR-56体外注射的最适剂量;罗氏沼虾其他免疫相关基因在注射antgomiR-56后的相对表达量均显著上升。【结论】 TLR1是novel miR-56的靶基因,其结合位点位于TLR1基因3'-UTR。novel miR-56通过靶向抑制TLR1基因表达而参与Toll信号通路调控,具有抑制罗氏沼虾免疫相关基因表达的功能。

     

    Abstract: 【Objective】 To analyze the regulatory role of novel miR-56 on immune-related genes in Macrobrachium rosenbergii, which could provide theoretical basis for further exploring the involvement of miRNAs in the immune regulation mechanism in M. rosenbergii. 【Method】 The expression changes of novel miR-56 in the gill tissues of Macrobrachium rosenbergii after Vibrio parahaemolyticus infection were detected by real-time fluorescence quantitative PCR. The potential target gene TLR1 of novel miR-56 was predicted and screened by RNAhybrid, and dual-luciferase reporter gene assay verified the targeting relationship between novel miR-56 and target gene TLR1. The expression of novel miR-56 was interfered by in vitro injection of agomiR-56 and antagomiR-56 at different concentrations(0.6, 1.0 and 1.5 μg/g), the optimal injection concentration of agomiR-56 and antagomiR-56 was screened, and changes in the expression of immunerelated genes of Macrobrachium rosenbergii were detected by rel-time fluorescence quantitative PCR. 【Result】 After infection with Vibrio parahaemolyticus, the relative expression level of novel miR-56 in the gill tissues of Macrobrachium rosenbergii showed a gradual upward trend with the progression of infection. At 72 h post-infection, the relative expression level of novel miR-56 was approximately as 6.18 times as that before infection(0 h). TLR1 was the target gene of novel miR-56, and the binding site between them was located in the 3’ untranslated region(3’-UTR) of TLR1 gene. Moreover, the overexpression of novel miR-56 could inhibit the expression of TLR1 gene. Intracardiac injection of agomiR-56 at doses of 0.6, 1.0 and 1.5 μg/g into Macrobrachium rosenbergii significantly inhibited the expression of TLR1 gene(P<0.05, the same below), with the optimal inhibitory effect observed at 1.5 μg/g agomiR-56. The relative expression levels of other immune-related genes in Macrobrachium rosenbergii(including Spz, TLR2, TLR3, MyD88, IMD, Crustin1, Wntless, ALF1 and proPO) also significantly decreased after agomiR-56 injection. In contrast, the results of the antagomiR-56 injection experiment showed the opposite trend. Injection of different doses of antagomiR-56 significantly promoted the expression of TLR1 gene in Macrobrachium rosenbergii. With the increase of injection dose, the promoting effect on TLR1 gene in Macrobrachium rosenbergii expression first increased and then decreased, and 1.0 μg/g was the optimal in vitro injection dose of antagomiR-56. The relative expression levels of other immune-related genes in in Macrobrachium rosenbergii significantly increased after antagomiR-56 injection. 【Conclusion】 TLR1 is a target gene of novel miR-56. The binding site is located in the 3’-UTR of TLR1 gene. Novel miR-56 regulates Toll signaling pathway by targeting and inhibiting TLR1 gene, and has the function of inhibiting the expression of immune-related genes in Macrobrachium rosenbergii.

     

/

返回文章
返回